用于转移性黑色素瘤的个体化树突状细胞疫苗。 - Suppr

Suppr

超能文献

Patient-specific dendritic-cell vaccines for metastatic melanoma.

作者信息

Dillman Robert O, Selvan Senthamil R, Schiltz Patric M

出版信息

N Engl J Med. 2006 Sep 14;355(11):1179-81. doi: 10.1056/NEJMc061667.

DOI:10.1056/NEJMc061667

PMID:16971731

Abstract

摘要

相似文献

Patient-specific dendritic-cell vaccines for metastatic melanoma.

N Engl J Med. 2006 Sep 14;355(11):1179-81. doi: 10.1056/NEJMc061667.

Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells.

J Dermatol. 2008 Dec;35(12):801-3. doi: 10.1111/j.1346-8138.2008.00575.x.

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.

J Immunother. 2006 Sep-Oct;29(5):545-57. doi: 10.1097/01.cji.0000211309.90621.8b.

Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.

Clin Cancer Res. 2006 Dec 15;12(24):7380-8. doi: 10.1158/1078-0432.CCR-06-1879.

Dendritic cell vaccination as a treatment modality for melanoma.

Expert Rev Anticancer Ther. 2009 Nov;9(11):1631-42. doi: 10.1586/era.09.139.

Dendritic cell immunotherapy for stage IV melanoma.

Melanoma Res. 2007 Oct;17(5):316-22. doi: 10.1097/CMR.0b013e3282c3a73b.

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.

Int J Oncol. 2006 Mar;28(3):585-93.

[Vaccination therapy of melanoma].

J Dtsch Dermatol Ges. 2005 Aug;3(8):630-45. doi: 10.1111/j.1610-0387.2005.05528.x.

Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.

J Clin Oncol. 2009 Feb 20;27(6):945-52. doi: 10.1200/JCO.2008.18.0794. Epub 2009 Jan 12.

Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.

Medicina (B Aires). 1997;57(4):421-7.

引用本文的文献

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines.

Hum Vaccin Immunother. 2023 Dec 31;19(1):2198467. doi: 10.1080/21645515.2023.2198467. Epub 2023 May 3.

Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment.

Biomedicines. 2019 Oct 11;7(4):80. doi: 10.3390/biomedicines7040080.

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma.

Melanoma Manag. 2019 May 31;6(2):MMT20. doi: 10.2217/mmt-2018-0010.

An update on the relevance of vaccine research for the treatment of metastatic melanoma.

Melanoma Manag. 2017 Dec;4(4):203-215. doi: 10.2217/mmt-2017-0021. Epub 2017 Nov 23.

Dendritic cell vaccines for melanoma: past, present and future.

Melanoma Manag. 2016 Dec;3(4):273-289. doi: 10.2217/mmt-2016-0014. Epub 2016 Nov 29.

Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.

Cancer Biother Radiopharm. 2015 Jun;30(5):187-94. doi: 10.1089/cbr.2015.1843.

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.

Cancer Immunol Immunother. 2011 Jan;60(1):123-31. doi: 10.1007/s00262-010-0925-y. Epub 2010 Oct 20.

Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.

J Clin Immunol. 2009 Sep;29(5):657-64. doi: 10.1007/s10875-009-9299-3. Epub 2009 May 7.

KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

J Clin Invest. 2008 Dec;118(12):3990-4001. doi: 10.1172/JCI31350. Epub 2008 Nov 6.

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia.

Cancer Immunol Immunother. 2008 Nov;57(11):1705-10. doi: 10.1007/s00262-008-0561-y. Epub 2008 Jul 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验